MDMaya Dadiani

Maya Dadiani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maya Dadiani has a total of 346 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis

    by Noa Furth, Christina Riemenschneider, Yishai Arieli, Matan Avni, Michael-Yakov Povolotski, Hadas Yung, Shiri Karagach, Ofir Atrakchi, Nir Erez, Tomer-Meir Salame, et al.

    Breast cancer, the most diagnosed cancer among women, is stratified by gene expression patterns into luminal and basal-like subtypes, and the latter is associated with worse prognosis1-3. Recent advances in single-cell technologies have underscored the presence of intratumour heterogeneity, which poses substantial challenges in cancer treatment and achieving long-term disease-free survival4-7. Here we extensively profile epigenetic heterogeneity in a cohort of treatment-naive human luminal tumours, which were obtained directly after surgical resection. By applying a single-cell epigenetic approach based on cytometry by time-of-flight, we identify a recurrent subpopulation of basal-like cells in luminal tumours with a conserved epigenetic signature across patients. These basal-like cells, also identified by deconvolution of whole-genome DNA methylation patterns, are characterized by high expression of aggressive oncogenic traits and downregulation of hormone receptor signalling. Direct comparison of single-cell proteomic and genomic profiling of monomethylation and trimethylation of histone 3 on lysine 4 revealed that these marks are key features associated with loss of luminal identity. Finally, we highlight the potential of concomitant single-molecule profiling of histone modifications on cell-free nucleosomes in blood as an epigenetic liquid biopsy approach for early diagnosis of breast cancer. Moreover, the epigenetic basal signature measured in blood is linked to prognosis, which enables the identification of patients at increased risk for disease relapse.

  • Open Access

    InSituPREP enables 3D single-cell mapping of interaction-associated gene programs in the breast cancer tumor microenvironment

    by Tal Goldberg, Michal Danino-Levi, Modi Safra, Yedaaya Copeland, Efrat R Weizman, Noa Konforti, Tal Ishon, Noga Ben-Ari, Yael Brand, Bareket Kruger, et al.

    Cell-cell interactions influence gene expression in the tumor microenvironment, yet despite advances in spatial transcriptomics that enable in situ expression profiling, current computational tools remain limited in quantitatively resolving single-cell and multicellular interaction effects across patient tissues. Here, we present InSituPREP (In Situ Proximity Expression Programs), a computational framework for quantifying how spatial context relates to transcriptional states in three-dimensional tissues at single-cell resolution. The framework quantifies proximity-associated gene programs across multiple analytical layers. We applied InSituPREP to Expansion Sequencing data from breast cancer biopsies of 10 patients, integrating newly generated and previously published datasets and profiling 299 cancer-related genes. This analysis revealed that a portion of within-cell type variability reflects proximity-associated transcriptional states, that proximity-dependent programs are reproducible across patients and measurement platforms, and that spatial RNA velocity links intercellular distance to future transcriptional trajectories. Linear modeling showed that gene expression in specific cell types varies with intercellular distance and the number of neighboring cells, while triplet configurations revealed additional interaction-associated programs. Moreover, simultaneous detection of bacterial signals and host mRNA enabled us to link bacterial proximity to distinct transcriptional responses. InSituPREP provides a framework for quantifying spatially associated gene expression and dissecting context-dependent transcriptional states at single-cell resolution.

  • Top Cited Papers

    Deep phenotyping of health–disease continuum in the Human Phenotype Project

    by Lee Reicher, Smadar Shilo, Anastasia Godneva, Guy Lutsker, Liron Zahavi, Saar Shoer, David Krongauz, Michal Rein, Sarah Kohn, Tomer Segev, et al.

    The Human Phenotype Project (HPP) is a large-scale deep-phenotype prospective cohort. To date, approximately 28,000 participants have enrolled, with more than 13,000 completing their initial visit. The project is aimed at identifying novel molecular signatures with diagnostic, prognostic and therapeutic value, and at developing artificial intelligence (AI)-based predictive models for disease onset and progression. The HPP includes longitudinal profiling encompassing medical history, lifestyle and nutrition, anthropometrics, blood tests, continuous glucose and sleep monitoring, imaging and multi-omics data, including genetics, transcriptomics, microbiome (gut, vaginal and oral), metabolomics and immune profiling. Analysis of these data highlights the variation of phenotypes with age and ethnicity and unravels molecular signatures of disease by comparison with matched healthy controls. Leveraging extensive dietary and lifestyle data, we identify associations between lifestyle factors and health outcomes. Finally, we present a multi-modal foundation AI model, trained using self-supervised learning on diet and continuous-glucose-monitoring data, that outperforms existing methods in predicting disease onset. This framework can be extended to integrate other modalities and act as a personalized digital twin. In summary, we present a deeply phenotyped cohort that serves as a platform for advancing biomarker discovery, enabling the development of multi-modal AI models and personalized medicine approaches.


  • Open Access

    Supplementary Table 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer

    by Aviad Ben-Shmuel, Yael Gruper, Coral Halperin, Oshrat Levi-Galibov, Hallel Rosenberg-Fogler, Debra Barki, Giulia Carradori, Yaniv Stein, Gal Yagel, Mariia Naumova, et al.

    Supplementary Table 2 shows RNA sequencing of mouse NK cells

  • Open Access

    Supplementary Video 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer

    by Aviad Ben-Shmuel, Yael Gruper, Coral Halperin, Oshrat Levi-Galibov, Hallel Rosenberg-Fogler, Debra Barki, Giulia Carradori, Yaniv Stein, Gal Yagel, Mariia Naumova, et al.

    Supplementary Video 2 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from a 2nd of 3 biologically independent experiments

  • Open Access

    Supplementary Table 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer

    by Aviad Ben-Shmuel, Yael Gruper, Coral Halperin, Oshrat Levi-Galibov, Hallel Rosenberg-Fogler, Debra Barki, Giulia Carradori, Yaniv Stein, Gal Yagel, Mariia Naumova, et al.

    Supplementary Table 3 shows IHC and MxIF staining data from 72 TNBC patient TMA

  • Open Access

    Supplementary Video 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer

    by Aviad Ben-Shmuel, Yael Gruper, Coral Halperin, Oshrat Levi-Galibov, Hallel Rosenberg-Fogler, Debra Barki, Giulia Carradori, Yaniv Stein, Gal Yagel, Mariia Naumova, et al.

    Supplementary Video 3 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is a close-up ROI of Supplementary Video 2

  • Open Access

    Data from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer

    by Aviad Ben-Shmuel, Yael Gruper, Coral Halperin, Oshrat Levi-Galibov, Hallel Rosenberg-Fogler, Debra Barki, Giulia Carradori, Yaniv Stein, Gal Yagel, Mariia Naumova, et al.

    Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096


  • Open Access

    Supplementary Figure 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer

    by Aviad Ben-Shmuel, Yael Gruper, Coral Halperin, Oshrat Levi-Galibov, Hallel Rosenberg-Fogler, Debra Barki, Giulia Carradori, Yaniv Stein, Gal Yagel, Mariia Naumova, et al.

    Supplementary Figure 3 shows upregulation of ligands for NK cell receptors on CAFs

  • Open Access

    Supplementary Video 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer

    by Aviad Ben-Shmuel, Yael Gruper, Coral Halperin, Oshrat Levi-Galibov, Hallel Rosenberg-Fogler, Debra Barki, Giulia Carradori, Yaniv Stein, Gal Yagel, Mariia Naumova, et al.

    Supplementary Video 1 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from 1 of 3 biologically independent experiments